ApprovalTrail

Drug · DIN 02399148

REFRESH OPTIVE ADVANCED

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since April 25, 2025; first marketed March 6, 2013.
Drug Identification Number (DIN)
02399148
Company (DIN owner)
AbbVie CorporationSaint-Laurent, Quebec, Canada
Schedule
Non-prescription drugs
Dosage form
Solution
Route
Ophthalmic
Therapeutic class (ATC)
Artificial tears and other indifferent preparations. S01XA20
Class
Human
Record last updated
June 16, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
CARBOXYMETHYLCELLULOSE SODIUM0.5 %
GLYCERINE1 %
POLYSORBATE 800.5 %